Return to course: The 16th Annual Sickle Cell Disease Research and Educational Symposium and 45th National Sickle Cell Disease Scientific Meeting

The 16th Annual Sickle Cell Disease Research and Educational Symposium and 45th National Sickle Cell Disease Scientific Meeting

Day 1

An Update on the NASEM Report

The Patient Symposium: Clinical Trials Participation and the Future of Sickle Cell Disease Therapies

Curative Therapies & Gene Therapy in Sickle Cell Disease Educational Session

Day 2

2022 Scientific Chair Welcome

Clinical Biomarkers in SCD: Envisioning a Care Model Focused on Health Maintenance Versus Crises Intervention Plenary Session

Alternative or Adjunct Therapies for Pain Management Educational Session

Biomarkers in Sickle Cell Disease: Real World Clinical Applications

Healthcare Screening in Sickle Cell Disease Educational Session

What COVID-19 Means for Sickle Cell Disease Patients Educational Session - Looking at the Vaccine & Other Approved Medications

Novartis’ Efforts in Ghana and Recognition of Dr. Kwaku "KOF" Ohene-Frempong’s Loving Tenacity for the Sickle Cell Disease Community Keynote Presentation

Investigational New Drug, Device and Therapeutics Symposium

Day 3

Scientific Keynote Presentation

Federal Agency Update

Dr. Kwaku “KOF” Ohene-Frempong East Meets West Global Sickle Cell Disease Symposium

Abstract Breakout Session l Basic Science

Abstract Breakout Session l Health Services

Abstract Breakout Session l Psychosocial

Abstract Breakout Session ll Clinical Research

Abstract Breakout Session ll Clinical Trials / Clinical Epidemiology

Abstract Breakout Session ll Health Services

What COVID-19 Means for Sickle Cell Disease Patients Educational Session – Looking at the Vaccine & Other Approved Medications

You are unauthorized to view this page.

Username

Password

Remember Me

Forgot Password